Patents by Inventor Vishal Deshmukh

Vishal Deshmukh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250093861
    Abstract: Managing tasks using an application-level blue-green topology with parallel cell infrastructure rails. Each cell infrastructure rail includes a dispatcher bot and a performer bot. The dispatcher bot is configured to prepare a work task based on a received request, and the performer bot performs the work task, resulting in performed work. A discovery server includes a service registry configured to store the states of the infrastructure rails. The discovery server receives the request for the work task, and sends the request to a dispatcher bot of a specific cell infrastructure rail based on the request and the states of the cell infrastructure rails. A respective workflow cell server receives the performed work. In the case that one cell infrastructure rail experiences a problem when processing the request, the cell infrastructure rails are switched to perform the request on the other cell infrastructure rail. The method implements the system.
    Type: Application
    Filed: July 30, 2024
    Publication date: March 20, 2025
    Applicant: Morgan Stanley Services Group Inc.
    Inventors: Sree Marudhalam, Vishal Deshmukh, Sujit Eapen
  • Patent number: 12190166
    Abstract: A method for monitoring and predicting batch activity in real time comprises obtaining i) ordered lists of jobs from scheduling platforms and ii) information related to jobs from one or more file transfer sources including real time event information, extracting data from the ordered lists of jobs and file transfer information, enriching the extracted data using additional information retrieved from at least one meta data repository, and generating a dependency graph that includes real time job and file transfer data obtained from the enriched data in which nodes of the graph represent events and edges represent relationships between the nodes indicating a dependence. Critical milestones are obtained from the dependency graph, critical paths for traversing the dependency graph for job and file transfer execution, and times for execution of each of the jobs and file transfers in the critical paths are predicted in real time.
    Type: Grant
    Filed: June 11, 2024
    Date of Patent: January 7, 2025
    Assignee: Morgan Stanley Service Group Inc.
    Inventors: Vishal Deshmukh, Sujit Eapen, Himanshu Rout, Rashad Barron, Rachit Mehrotra, Tanmay Nagar, Tejas Shah
  • Patent number: 12078985
    Abstract: Managing tasks using an application-level blue-green topology with parallel cell infrastructure rails. Each cell infrastructure rail includes a dispatcher bot and a performer bot. The dispatcher bot is configured to prepare a work task based on a received request, and the performer bot performs the work task, resulting in performed work. A discovery server includes a service registry configured to store the states of the infrastructure rails. The discovery server receives the request for the work task, and sends the request to a dispatcher bot of a specific cell infrastructure rail based on the request and the states of the cell infrastructure rails. A respective workflow cell server receives the performed work. In the case that one cell infrastructure rail experiences a problem when processing the request, the cell infrastructure rails are switched to perform the request on the other cell infrastructure rail. The method implements the system.
    Type: Grant
    Filed: September 19, 2023
    Date of Patent: September 3, 2024
    Assignee: Morgan Stanley Services Group Inc.
    Inventors: Sree Marudhalam, Vishal Deshmukh, Sujit Eapen
  • Patent number: 11684615
    Abstract: This disclosure features the use of one or more indazole-3-carboxamide compounds or salts or analogs thereof, in the treatment of one or more diseases or conditions independently selected from the group consisting of a tendinopathy, dermatitis, psoriasis, morphea, ichthyosis, Raynaud's syndrome, and Darier's disease; and/or for promoting wound healing. The methods include administering to a subject (e.g., a subject in need thereof) a therapeutically effective amount of one or more indazole-3-carboxamide compounds or salts or analogs thereof as described anywhere herein.
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: June 27, 2023
    Assignee: BioSplice Therapeutics, Inc.
    Inventors: Vishal Deshmukh, Eric Anthony Murphy, John Hood
  • Publication number: 20230000842
    Abstract: Provided herein are methods of treating cartilage disorders in a subject using a dual CLK/DYRK inhibitor, or a pharmaceutically acceptable salt of solvate thereof, or a combination of a CLK inhibitor, or a pharmaceutically acceptable salt of solvate thereof, and DYRK inhibitor or, pharmaceutically acceptable salt or solvate thereof.
    Type: Application
    Filed: January 17, 2020
    Publication date: January 5, 2023
    Inventors: Vishal Deshmukh, Alyssa-Lauren O'Green, Carine Bossard, Charlene F. Barroga, John Hood
  • Patent number: 11246873
    Abstract: The present invention provides methods of inducing differentiation of oligodendrocyte progenitor cells to a mature myelinating cell fate with a neurotransmitter receptor modulating agent. The present invention also provides methods of stimulating increased myelination in a subject in need thereof by administering said neurotransmitter receptor modulating agent. Methods of treating a subject having a demyelinating disease using a neurotransmitter receptor modulating agent are also provided.
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: February 15, 2022
    Assignee: The Scripps Research Institute
    Inventors: Peter Schultz, Luke Lairson, Vishal Deshmukh, Costas Lyssiotis
  • Publication number: 20210121448
    Abstract: This disclosure features the use of one or more indazole-3-carboxamide compounds or salts or analogs thereof, in the treatment of one or more diseases or conditions independently selected from the group consisting of a tendinopathy, dermatitis, psoriasis, morphea, ichthyosis, Raynaud's syndrome, and Darier's disease; and/or for promoting wound healing. The methods include administering to a subject (e.g., a subject in need thereof) a therapeutically effective amount of one or more indazole-3-carboxamide compounds or salts or analogs thereof as described anywhere herein.
    Type: Application
    Filed: June 29, 2020
    Publication date: April 29, 2021
    Inventors: Vishal Deshmukh, Eric Anthony Murphy, John Hood
  • Publication number: 20200390780
    Abstract: The present invention provides methods of inducing differentiation of oligodendrocyte progenitor cells to a mature myelinating cell fate with a neurotransmitter receptor modulating agent. The present invention also provides methods of stimulating increased myelination in a subject in need thereof by administering said neurotransmitter receptor modulating agent. Methods of treating a subject having a demyelinating disease using a neurotransmitter receptor modulating agent are also provided.
    Type: Application
    Filed: April 8, 2020
    Publication date: December 17, 2020
    Inventors: Peter Schultz, Luke Lairson, Vishal Deshmukh, Costas Lyssiotis
  • Patent number: 10806726
    Abstract: This disclosure features the use of one or more indazole-3-carboxamide compounds or salts or analogs thereof, in the treatment of one or more diseases or conditions independently selected from the group consisting of a tendinopathy, dermatitis, psoriasis, morphea, ichthyosis, Raynaud's syndrome, and Darier's disease; and/or for promoting wound healing. The methods include administering to a subject (e.g., a subject in need thereof) a therapeutically effective amount of one or more indazole-3-carboxamide compounds or salts or analogs thereof as described anywhere herein.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: October 20, 2020
    Assignee: Samumed, LLC
    Inventors: Vishal Deshmukh, Eric Anthony Murphy, John Hood
  • Patent number: 10660899
    Abstract: The present invention provides methods of inducing differentiation of oligodendrocyte progenitor cells to a mature myelinating cell fate with a neurotransmitter receptor modulating agent. The present invention also provides methods of stimulating increased myelination in a subject in need thereof by administering said neurotransmitter receptor modulating agent. Methods of treating a subject having a demyelinating disease using a neurotransmitter receptor modulating agent are also provided.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: May 26, 2020
    Assignees: The Scripps Research Institute, Novartis AG
    Inventors: Peter Schultz, Luke Lairson, Vishal Deshmukh, Costas Lyssiotis
  • Patent number: 10493080
    Abstract: The present invention provides methods of inducing differentiation of oligodendrocyte progenitor cells to a mature myelinating cell fate with a neurotransmitter receptor modulating agent. The present invention also provides methods of stimulating increased myelination in a subject in need thereof by administering said neurotransmitter receptor modulating agent. Methods of treating a subject having a demyelinating disease using a neurotransmitter receptor modulating agent are also provided.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: December 3, 2019
    Assignees: The Scripps Research Institute, Novartis AG
    Inventors: Peter Schultz, Luke Lairson, Vishal Deshmukh, Costas Lyssiotis
  • Publication number: 20180185343
    Abstract: This disclosure features the use of one or more indazole-3-carboxamide compounds or salts or analogs thereof, in the treatment of one or more diseases or conditions independently selected from the group consisting of a tendinopathy, dermatitis, psoriasis, morphea, ichthyosis, Raynaud's syndrome, and Darier's disease; and/or for promoting wound healing. The methods include administering to a subject (e.g., a subject in need thereof) a therapeutically effective amount of one or more indazole-3-carboxamide compounds or salts or analogs thereof as described anywhere herein.
    Type: Application
    Filed: October 23, 2017
    Publication date: July 5, 2018
    Inventors: Vishal Deshmukh, Eric Anthony Murphy, John Hood
  • Publication number: 20170136029
    Abstract: The present invention provides methods of inducing differentiation of oligodendrocyte progenitor cells to a mature myelinating cell fate with a neurotransmitter receptor modulating agent. The present invention also provides methods of stimulating increased myelination in a subject in need thereof by administering said neurotransmitter receptor modulating agent. Methods of treating a subject having a demyelinating disease using a neurotransmitter receptor modulating agent are also provided.
    Type: Application
    Filed: January 27, 2017
    Publication date: May 18, 2017
    Inventors: Peter Schultz, Luke Lairson, Vishal Deshmukh, Costas Lyssiotis
  • Patent number: 9592288
    Abstract: The present invention provides methods of inducing differentiation of oligodendrocyte progenitor cells to a mature myelinating cell fate with a neurotransmitter receptor modulating agent. The present invention also provides methods of stimulating increased myelination in a subject in need thereof by administering said neurotransmitter receptor modulating agent. Methods of treating a subject having a demyelinating disease using a neurotransmitter receptor modulating agent are also provided.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: March 14, 2017
    Assignees: The Scripps Research Institute, IRM LLC
    Inventors: Peter Schultz, Luke Lairson, Vishal Deshmukh, Costas Lyssiotis
  • Publication number: 20160166687
    Abstract: The present invention provides methods of inducing differentiation of oligodendrocyte progenitor cells to a mature myelinating cell fate with a neurotransmitter receptor modulating agent. The present invention also provides methods of stimulating increased myelination in a subject in need thereof by administering said neurotransmitter receptor modulating agent. Methods of treating a subject having a demyelinating disease using a neurotransmitter receptor modulating agent are also provided.
    Type: Application
    Filed: December 17, 2015
    Publication date: June 16, 2016
    Inventors: Peter Schultz, Luke Lairson, Vishal Deshmukh, Costas Lyssiotis
  • Publication number: 20140038949
    Abstract: The present invention provides methods of inducing differentiation of oligodendrocyte progenitor cells to a mature myelinating cell fate with a neurotransmitter receptor modulating agent. The present invention also provides methods of stimulating increased myelination in a subject in need thereof by administering said neurotransmitter receptor modulating agent. Methods of treating a subject having a demyelinating disease using a neurotransmitter receptor modulating agent are also provided.
    Type: Application
    Filed: February 17, 2012
    Publication date: February 6, 2014
    Applicants: IRM LLC, The Scripps Research Institute
    Inventors: Peter Schultz, Luke Lairson, Vishal Deshmukh, Costas Lyssiotis
  • Publication number: 20060195750
    Abstract: A troubleshooting tool for simplifying troubleshooting of errors in configurable parameter values associated with computer supported business-flows. The parameter values affecting the business-flows are stored in the tables of a database system in one embodiment. An administrator specifies the set of parameters which determine the specific row of the table that would be used by the business-flow, and the manner (e.g., as an SQL query) in which the specific row is determined. A user then invokes the tool, selects a specific business-flow (or parameter) to troubleshoot. The tool receives values for the set of parameters specified by the administrator and retrieves the specific data element representing the value of the parameter of interest (according to the SQL query). The retrieved data element can be compared with an expected value to troubleshoot the business-flow.
    Type: Application
    Filed: April 10, 2005
    Publication date: August 31, 2006
    Applicant: ORACLE INTERNATIONAL CORPORATION
    Inventors: Vishal Deshmukh, Venkanna Mittakanti